Congress Stalls SBIR Reauthorization, Leaving Small Business Grants Frozen

Six months after Congress allowed the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs to expire, federal agencies still cannot issue new awards—and there is no clear timeline for resolution.

What Happened to America's Top Small Business R&D Programs

The legislative authority for both programs lapsed on October 1, 2025. NIH promptly terminated all active SBIR/STTR Notices of Funding Opportunity and confirmed it will not accept applications for the April 5, 2026 standard receipt date. Other participating agencies face the same constraint: without congressional reauthorization, no new solicitations can be issued and no new awards can be made.

The freeze extends beyond new applications. NIH has stated that noncompeting continuation awards—the multi-year funding that sustains ongoing Phase I and Phase II projects—will not be issued until Congress acts. For small businesses counting on that revenue, the disruption is acute.

Two Bills, Zero Progress

The House passed H.R. 5100, a clean one-year extension, unanimously in September 2025. The bill sits in the Senate Small Business and Entrepreneurship Committee, blocked by Senator Joni Ernst, who insists on attaching her INNOVATE Act. That bill would impose a $75 million lifetime funding cap per organization, limit principal investigators to one application per solicitation, and create a new Phase 1A award category funded at 2.5% of agency SBIR budgets.

Democratic senators have threatened to block Ernst's unanimous consent vote, creating a stalemate. Neither President Trump nor Senate leadership has publicly intervened. The most likely reauthorization vehicle remains the FY2027 National Defense Authorization Act, which could move later this year.

Three Moves Small Businesses Should Make Now

First, monitor existing awards closely—continuation funding is paused, not canceled, but cash flow planning is critical. Second, explore non-SBIR alternatives: agency-specific BAAs, DARPA open solicitations, and DOE funding opportunities remain active and unaffected by the lapse. Third, prepare applications now so you can submit quickly when reauthorization passes.

Grant seekers tracking this issue can find deeper strategic analysis on the Granted blog.